Europe Clinical Nutrition Market Size
| Study Period | 2019-2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 21.02 Billion |
| Market Size (2029) | USD 31.39 Billion |
| CAGR (2024 - 2029) | 8.35 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Clinical Nutrition Market Analysis
The Europe Clinical Nutrition Market size is estimated at USD 21.02 billion in 2024, and is expected to reach USD 31.39 billion by 2029, growing at a CAGR of 8.35% during the forecast period (2024-2029).
COVID-19 infection became a major public health concern, and clinical nutrition played a crucial role in preventing infection and treating infection-associated malnutrition. Major micronutrients such as vitamins A, B6, B12, folate, C, D, and E and trace elements (Zinc, Selenium, and Copper) are known to play important roles in regulating both innate and adaptive immune responses, which were essential to maintaining during COVID-19. Further, according to the article published by researchers in Europe in December 2022 in the Clinical Nutrition journal, COVID-19 significantly induced severe alterations in the patient's nutritional status, which notably impacted the clinical outcomes. Due to this, the adoption of clinical nutrition products was significantly high during the pandemic, which positively impacted the growth of the studied market over the forecast period. In the current scenario, the market is experiencing its pre-pandemic trends due to the increase in demand for clinical nutrition products as COVID-19-related restrictions have been eased.
The major factors attributing to the growth of the market are the increasing prevalence of metabolic disorders and high spending on healthcare. For instance, according to the 2022 statistics published by the International Diabetes Federation (IDF) Diabetes Atlas, 3.94 million people were diagnosed with diabetes in France in 2021. This number is expected to rise to 4.18 million by 2030 and 4.22 million by 2040 in France. Thus, the increasing burden of diabetes in the region is expected to increase the demand for clinical nutrition, thereby boosting the market growth.
Furthermore, the increasing government initiatives in launching guidelines and aware people regarding clinical nutrition are also contributing to the growth of the market. For instance, in November 2022, German hospitals and nursing homes took part in the new nDay campaign launched by the German Federal Ministry of Food and Agriculture (BMEL) in cooperation with the Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, the German Clinical Nutrition Society (DGEM), and the German Nutrition Society (DGE) to support nationwide participation in the nutritionDay audit (nDay). The campaign provided current data on the prevalence of malnutrition as well as existing care structures in hospitals and nursing homes in Germany. Similarly, in January 2022, World Health Organization/Europe launched a new, voluntary, Member State-led Sugar and Calorie Reduction Network to promote healthier diets as well as reduce overweight and obesity levels across the World Health Organization European Region.
Furthermore, the presence of key market players and their strategic activities, like product launches, agreements, and collaboration to increase product availability in Europe, is further expected to bolster market growth over the forecast period. For instance, in April 2022, Glanbia Nutritionals launched TechVantage at the nutraceutical event Vitafoods Europe. TechVantage will provide customers with nutrient solutions with stability enhancements, the ability to mask flavors/colors, and solubility/flowability improvements. Similarly, in November 2022, Dairy Cooperative Laïta Nutrition launched DADFMS, a powder-based nutritional solution based on dairy proteins, which effectively meets the needs of patients suffering from or at risk of malnutrition (FSMPs). Laïta Nutrition developed this prepacked powder because many pathologies hinder patient autonomy and are associated with swallowing disorders, often leading to the long-term deterioration of nutritional status.
However, imprecise perceptions about clinical nutrition are likely to restrain the market growth over the forecast period.
Europe Clinical Nutrition Market Trends
Metabolic Disorders Segment Expects to Witness a Significant Market Growth Over the Forecast Period
The metabolic disorders segment is expected to witness significant growth over the forecast period owing to factors such as the rising prevalence of metabolic disorders such as diabetes, Phenylketonuria (PKU), Porphyria, Gaucher Disease, and others among the population. For instance, according to the article published in June 2023 in the Cureus journal, PKU is one of the most well-known inborn metabolic disorders, with a prevalence of 1/100,000 live births in Europe. Thus, the high burden of metabolic diseases like PKU among the population is expected to increase the demand for nutrition therapy to control the levels of phenylalanine, which is expected to augment the market growth over the forecast period.
In addition, the rising geriatric population in the region is also contributing to the growth of the market. For instance, as per the October 2022 update by Eurostat, the population of older people in the EU-27 is expected to reach 129.8 million by 2050. The number of the elderly population is expected to increase shortly, who are more prone to metabolic, neurological, and other disorders. This is expected to raise the demand for clinical nutrition products, propelling the segment growth over the forecast period.
Furthermore, the increasing company activities for providing nutrition products to the people in the region are expected to increase the demand for clinical nutritional products, thereby boosting market growth. For instance, in March 2022, Cymbiotika launched a new e-commerce store in the United Kingdom that offers quick access to Cymbiotika's rapidly growing line of natural supplements. Additionally, in June 2022, Fresenius Kabi UK launched a website to support healthcare professionals working in the field of parenteral nutrition. This website contains information about the use of standardized parenteral nutrition and includes product information for the Fresenius Kabi range of multi-chamber bags.
Thus, the increasing burden of metabolic disorders, the growing geriatric population, and rising company activities in the region are expected to increase the demand for clinical nutrition therapy and products to reduce the risks of developing chronic diseases, which is expected to augment the market growth over the forecast period.
United Kingdom is Expected to Hold a Significant Market Share Over the Forecast Period
The United Kingdom is expected to witness significant growth in the studied market owing to factors such as an increase in malnutrition cases, a rise in awareness for clinical nutrition, and a surge in strategic initiatives by the key players. For instance, as per the January 2023 update by the Malnutrition Task Force in the UK, estimates suggest that 1.3 million people over 65 suffer from malnutrition, and the vast majority (93%) live in the community. Also, as per the same source, one-third (32%) of people in the UK aged 65 years or over are at risk of malnutrition on admission to the hospital. Thus, an increase in malnutrition cases is expected to increase the demand for clinical nutrition, thereby boosting the segment growth over the forecast period.
Furthermore, an increase in strategic activities by the key players and government initiatives to improve the clinical nutrition uptake are expected to bolster market growth. For instance, in March 2022, BSNA supported Nutrition and Hydration Week, which promoted good practices in preventing malnutrition and dehydration with health and social care professionals. Similarly, in October 2023, the British Association for Parenteral and Enteral Nutrition (BAPEN) joined forces with the Malnutrition Task Force (MTF) to run UK Malnutrition Awareness Week 2023 to increase the understanding of the dangers, risk factors, and signs of malnutrition and dehydration.
Therefore, due to the rise in malnutrition cases and the increase in awareness campaigns of clinical nutrition, the United Kingdom is expected to witness significant growth over the forecast period.
Europe Clinical Nutrition Industry Overview
The European clinical nutrition market is moderately consolidated and consists of a few major players. In terms of market share, a few of the major players are currently dominating the market. Some of the major players in the market are Abbott, Nestle Health Science, Baxter International, B. Braun SE, and Danone S.A. (Nutricia), among others.
Europe Clinical Nutrition Market Leaders
-
Danone S.A. (Nutricia)
-
Abbott
-
Nestlé (Nestlé Health Science)
-
Baxter International
-
B. Braun SE
*Disclaimer: Major Players sorted in no particular order
Europe Clinical Nutrition Market News
- January 2023: Nutricia Netherlands launched its first plant-based, ready-to-drink, oral nutritional supplement, Fortimel PlantBased Energy, specifically formulated to meet the nutritional needs of people who are malnourished or at risk of malnutrition due to illness.
- January 2023: The National Agency for the Safety of Medicines and Health Products (ANSM) in France launched a public consultation on pediatric parenteral nutrition preparations. Two draft monographs for infusion and emulsion are submitted for the opinion of parenteral nutrition prescribers, hospital pharmacists, and health establishments that produce these preparations in France.
Europe Clinical Nutrition Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Prevalence of Metabolic Disorders
- 4.2.2 High Spending on Healthcare and Rise in Geriatric Population
-
4.3 Market Restraints
- 4.3.1 Imprecise Perception About Clinical Nutrition
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Suppliers
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Route of Administration
- 5.1.1 Oral and Enteral
- 5.1.2 Parenteral
-
5.2 By Application
- 5.2.1 Malnutrition
- 5.2.2 Metabolic Disorders
- 5.2.3 Gastrointestinal Diseases
- 5.2.4 Cancer
- 5.2.5 Neurological Diseases
- 5.2.6 Other Diseases
-
5.3 By End User
- 5.3.1 Pediatric
- 5.3.2 Adult
-
5.4 Geography
- 5.4.1 Germany
- 5.4.2 United Kingdom
- 5.4.3 France
- 5.4.4 Italy
- 5.4.5 Spain
- 5.4.6 Rest of Europe
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Abbott
- 6.1.2 Nestlé (Nestlé Health Science)
- 6.1.3 Baxter International
- 6.1.4 B. Braun SE
- 6.1.5 Danone S.A. (Nutricia)
- 6.1.6 Reckitt Benckiser Group PLC (Mead Johnson)
- 6.1.7 Perrigo Company PLC
- 6.1.8 Fresenius SE & Co. KGaA
- 6.1.9 AYMES International Ltd.
- 6.1.10 Medifood International Ltd.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityEurope Clinical Nutrition Industry Segmentation
As per the scope of the report, clinical nutrition is the overall analysis of the relationship between ingested food and the overall well-being of the human body. Clinical nutrition is largely concerned with the prevention, diagnosis, and management of nutritional alterations in individuals who have chronic illnesses and disorders. Clinical nutrition products are useful in maintaining the patient's health and enabling the improvement of the body's metabolic system by providing adequate supplements, such as minerals, vitamins, and other supplements. The European clinical nutrition market is segmented by route of administration (oral, enteral, and parenteral), application (malnutrition, metabolic disorders, gastrointestinal diseases, cancer, neurological diseases, and other diseases), end user (pediatrics and adults), and geography (Germany, the United Kingdom, France, Italy, Spain, and the rest of Europe).
The report offers the value (in USD) for the above segments.
| By Route of Administration | Oral and Enteral |
| Parenteral | |
| By Application | Malnutrition |
| Metabolic Disorders | |
| Gastrointestinal Diseases | |
| Cancer | |
| Neurological Diseases | |
| Other Diseases | |
| By End User | Pediatric |
| Adult | |
| Geography | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe |
Europe Clinical Nutrition Market Research FAQs
How big is the Europe Clinical Nutrition Market?
The Europe Clinical Nutrition Market size is expected to reach USD 21.02 billion in 2024 and grow at a CAGR of 8.35% to reach USD 31.39 billion by 2029.
What is the current Europe Clinical Nutrition Market size?
In 2024, the Europe Clinical Nutrition Market size is expected to reach USD 21.02 billion.
Who are the key players in Europe Clinical Nutrition Market?
Danone S.A. (Nutricia), Abbott, Nestlé (Nestlé Health Science), Baxter International and B. Braun SE are the major companies operating in the Europe Clinical Nutrition Market.
What years does this Europe Clinical Nutrition Market cover, and what was the market size in 2023?
In 2023, the Europe Clinical Nutrition Market size was estimated at USD 19.26 billion. The report covers the Europe Clinical Nutrition Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Clinical Nutrition Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Europe Clinical Nutrition Industry Report
Statistics for the 2024 Europe Parenteral Nutrition market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Parenteral Nutrition analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
